本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

19.71
+0.36001.86%
成交量:25.94萬
成交額:509.45萬
市值:24.77億
市盈率:-10.97
高:19.93
開:19.55
低:19.42
收:19.35
資料載入中...
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/22

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/22

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]